• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下一代测序在肺鳞状细胞癌诊断中的临床应用:原发性还是继发性?

Clinical Application of Next-generation Sequencing for the Diagnosis of Lung Squamous Cell Carcinoma: Is It Primary or Secondary?

作者信息

Aizawa Hiroaki, Karasaki Takahiro, Nagayama Kazuhiro, Shinozaki-Ushiku Aya, Aburatani Hiroyuki, Mano Hiroyuki, Nakajima Jun

机构信息

Department of Thoracic Surgery, The University of Tokyo Graduate School of Medicine, Japan.

Department of Pathology, The University of Tokyo Graduate School of Medicine, Japan.

出版信息

Intern Med. 2020 May 15;59(10):1299-1302. doi: 10.2169/internalmedicine.3682-19. Epub 2020 Feb 12.

DOI:10.2169/internalmedicine.3682-19
PMID:32051379
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7303454/
Abstract

An 80-year-old man with a history of cutaneous squamous cell carcinoma (SCC) was referred to our department for a solitary lung nodule. The nodule was surgically resected and diagnosed as SCC. Because the lung lesion and a previous skin lesion showed similar histological findings, the origin of the lung tumor was uncertain. Next-generation sequencing using a targeted driver oncogene panel was applied for the further examination. The lung lesion was diagnosed as primary lung SCC, as the two tumors possessed distinct somatic mutations in TP53. Recent advances in clinical sequencing have enabled us to obtain an accurate diagnosis in pathologically challenging cases.

摘要

一名有皮肤鳞状细胞癌(SCC)病史的80岁男性因孤立性肺结节被转诊至我科。该结节经手术切除,诊断为SCC。由于肺部病变和先前的皮肤病变显示出相似的组织学特征,肺肿瘤的起源尚不确定。应用靶向驱动癌基因panel的二代测序进行进一步检查。由于两个肿瘤在TP53基因中存在不同的体细胞突变,肺部病变被诊断为原发性肺SCC。临床测序的最新进展使我们能够在病理诊断具有挑战性的病例中获得准确诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b8/7303454/76a13faf67c3/1349-7235-59-1299-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b8/7303454/77da53bc7736/1349-7235-59-1299-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b8/7303454/76a13faf67c3/1349-7235-59-1299-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b8/7303454/77da53bc7736/1349-7235-59-1299-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b8/7303454/76a13faf67c3/1349-7235-59-1299-g002.jpg

相似文献

1
Clinical Application of Next-generation Sequencing for the Diagnosis of Lung Squamous Cell Carcinoma: Is It Primary or Secondary?下一代测序在肺鳞状细胞癌诊断中的临床应用:原发性还是继发性?
Intern Med. 2020 May 15;59(10):1299-1302. doi: 10.2169/internalmedicine.3682-19. Epub 2020 Feb 12.
2
Squamous cell carcinoma initially occurring on the tongue dorsum: a case series report with molecular analysis.舌背初发的鳞状细胞癌:系列病例报告并结合分子分析
Diagn Pathol. 2024 Apr 22;19(1):63. doi: 10.1186/s13000-024-01487-0.
3
Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor types.鳞状特性:新一代测序揭示了跨鳞状肿瘤类型的共同分子特征。
Cell Cycle. 2015;14(14):2355-61. doi: 10.1080/15384101.2015.1053669. Epub 2015 Jun 1.
4
Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria.根据世界卫生组织2015年标准重新分类的一组肺大细胞癌的下一代测序
Arch Pathol Lab Med. 2016 Apr;140(4):312-7. doi: 10.5858/arpa.2015-0361-OA. Epub 2015 Oct 2.
5
Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.靶向测序揭示TP53作为头颈部癌治疗后监测中的潜在诊断生物标志物。
Oncotarget. 2016 Sep 20;7(38):61575-61586. doi: 10.18632/oncotarget.11196.
6
Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.用于鉴别肺腺癌和肺鳞癌的最佳免疫组织化学组合:在肺切除标本中的组织微阵列检测。
Ann Diagn Pathol. 2013 Feb;17(1):85-90. doi: 10.1016/j.anndiagpath.2012.07.006. Epub 2012 Oct 4.
7
Combined human papillomavirus typing and TP53 mutation analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.联合人乳头瘤病毒分型和 TP53 突变分析在鉴别头颈部鳞状细胞癌患者的第二原发肿瘤与肺转移瘤。
Head Neck. 2018 Jun;40(6):1109-1119. doi: 10.1002/hed.25041. Epub 2018 Mar 9.
8
Analysis of Fifty Hotspot Mutations of Lung Squamous Cell Carcinoma in Never-smokers.从不吸烟者肺鳞状细胞癌50个热点突变的分析
J Korean Med Sci. 2017 Mar;32(3):415-420. doi: 10.3346/jkms.2017.32.3.415.
9
Targeted DNA sequencing for assessing clonality in multiple lung tumors: A new approach to an old dilemma.靶向 DNA 测序评估多个肺部肿瘤的克隆性:一个老问题的新方法。
Lung Cancer. 2018 Aug;122:120-123. doi: 10.1016/j.lungcan.2018.05.029. Epub 2018 Jun 1.
10
Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.临床下一代测序成功应用于肺和胰腺肿瘤的细针抽吸。
Cancer Cytopathol. 2013 Dec;121(12):688-94. doi: 10.1002/cncy.21338. Epub 2013 Jul 24.

本文引用的文献

1
Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens.通过从福尔马林固定石蜡包埋标本中进行靶向富集,对癌症进行全面的分子谱分析。
Cancer Sci. 2019 Apr;110(4):1464-1479. doi: 10.1111/cas.13968. Epub 2019 Mar 5.
2
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer.肺癌诊断免疫组织化学的最佳实践推荐。
J Thorac Oncol. 2019 Mar;14(3):377-407. doi: 10.1016/j.jtho.2018.12.005. Epub 2018 Dec 18.
3
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
一线纳武利尤单抗用于IV期或复发性非小细胞肺癌
N Engl J Med. 2017 Jun 22;376(25):2415-2426. doi: 10.1056/NEJMoa1613493.
4
Mutational analysis of multiple lung cancers: Discrimination between primary and metastatic lung cancers by genomic profile.多例肺癌的突变分析:通过基因组图谱区分原发性和转移性肺癌。
Oncotarget. 2017 May 9;8(19):31133-31143. doi: 10.18632/oncotarget.16096.
5
Suspected Pulmonary Metastasis of Actinic Cutaneous Squamous Cell Carcinoma.光化性皮肤鳞状细胞癌疑似肺转移
Case Rep Surg. 2017;2017:4176071. doi: 10.1155/2017/4176071. Epub 2017 Mar 13.
6
The Eighth Edition Lung Cancer Stage Classification.《第八版肺癌分期分类》
Chest. 2017 Jan;151(1):193-203. doi: 10.1016/j.chest.2016.10.010. Epub 2016 Oct 22.
7
Differential diagnosis between primary lung squamous cell carcinoma and pulmonary metastasis of head and neck squamous cell carcinoma.原发性肺鳞状细胞癌与头颈部鳞状细胞癌肺转移的鉴别诊断。
Expert Rev Anticancer Ther. 2016;16(4):403-10. doi: 10.1586/14737140.2016.1147352. Epub 2016 Feb 16.
8
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.纪念斯隆凯特琳癌症中心可操作癌症靶点综合突变分析(MSK-IMPACT):一种基于杂交捕获的实体瘤分子肿瘤学新一代测序临床检测方法。
J Mol Diagn. 2015 May;17(3):251-64. doi: 10.1016/j.jmoldx.2014.12.006. Epub 2015 Mar 20.
9
Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer.下一代测序技术揭示了非小细胞肺癌患者的原发肿瘤和转移灶之间反复出现的体细胞改变具有高度一致性。
J Clin Oncol. 2013 Jun 10;31(17):2167-72. doi: 10.1200/JCO.2012.47.7737. Epub 2013 Apr 29.
10
Intratumor heterogeneity: evolution through space and time.肿瘤内异质性:时空演变。
Cancer Res. 2012 Oct 1;72(19):4875-82. doi: 10.1158/0008-5472.CAN-12-2217. Epub 2012 Sep 20.